167 related articles for article (PubMed ID: 34320862)
1. Superiority of Rituximab Over Mycophenolate Mofetil in the Treatment of Pemphigus Vulgaris: A Step Further in Its Approval as a First-Line Treatment?
Lemieux A; Saber M; Côté B
J Cutan Med Surg; 2022; 26(1):103-104. PubMed ID: 34320862
[No Abstract] [Full Text] [Related]
2. Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil.
Biot Sdel R; Franco JP; Lima RB; Pereira HN; Marques LP; Martins CJ
An Bras Dermatol; 2014; 89(6):980-4. PubMed ID: 25387507
[TBL] [Abstract][Full Text] [Related]
3. Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris.
Chen MKY; Vissapragada R; Bulamu N; Gupta M; Werth V; Sebaratnam DF
JAMA Dermatol; 2022 Sep; 158(9):1013-1021. PubMed ID: 35895045
[TBL] [Abstract][Full Text] [Related]
4. Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
Werth VP; Joly P; Mimouni D; Maverakis E; Caux F; Lehane P; Gearhart L; Kapre A; Pordeli P; Chen DM;
N Engl J Med; 2021 Jun; 384(24):2295-2305. PubMed ID: 34097368
[TBL] [Abstract][Full Text] [Related]
5. Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris.
Hopkins ZH; Wu BC; Nousari CH
N Engl J Med; 2021 Sep; 385(11):1055-1056. PubMed ID: 34496187
[No Abstract] [Full Text] [Related]
6. Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris. Reply.
Werth VP; Joly P; Chen DM
N Engl J Med; 2021 Sep; 385(11):1056. PubMed ID: 34496188
[No Abstract] [Full Text] [Related]
7. [Therapy of pemphigus].
van Beek N; Zillikens D; Schmidt E
Hautarzt; 2019 Apr; 70(4):243-253. PubMed ID: 30887081
[TBL] [Abstract][Full Text] [Related]
8. [Unexpected positive outcome following rituximab treatment in a patient with pemphigus vegetans resistant to conventional therapies: a case report].
Barbach Y; Baybay H; Mrabat S; Chaouche M; Elloudi S; Mernissi FZ
Pan Afr Med J; 2019; 32():101. PubMed ID: 31223391
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness and safety of rituximab in pemphigus vulgaris].
Alonso Sánchez A; García Rodríguez S; López Avila A; Rabell Iñigo S
Farm Hosp; 2010; 34(2):98-9. PubMed ID: 20304370
[No Abstract] [Full Text] [Related]
11. Treatment outcomes in a cohort of patients with mucosal-predominant pemphigus vulgaris.
Ojaimi S; O'Connor K; Lin MW; Schifter M; Fulcher DA
Intern Med J; 2015 Mar; 45(3):284-92. PubMed ID: 25534017
[TBL] [Abstract][Full Text] [Related]
12. Clinical resolution of pemphigus vulgaris on rituximab.
Cusick E; Silverstein D
Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469734
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
Esmaili N; Chams-Davatchi C; Valikhani M; Farshidfar F; Parvaneh N; Tamizifar B
Eur J Dermatol; 2008; 18(2):159-64. PubMed ID: 18424375
[TBL] [Abstract][Full Text] [Related]
14. Rituximab administration in a patient with pemphigus vulgaris following reactivation of occult hepatitis B virus infection.
Tavakolpour S; Soori T; Noormohammadpour P; Balighi K; Mahmoudi H; Daneshpazhooh M
Dermatol Online J; 2017 Jun; 23(6):. PubMed ID: 28633752
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
Doukaki S; Platamone A; Alaimo R; Bongiorno MR
J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
[TBL] [Abstract][Full Text] [Related]
16. Rituximab Therapy for Childhood Pemphigus Vulgaris.
Kincaid L; Weinstein M
Pediatr Dermatol; 2016; 33(2):e61-4. PubMed ID: 26765543
[TBL] [Abstract][Full Text] [Related]
17. Network meta-analysis-based comparison of first-line steroid-sparing adjuvants in the treatment of pemphigus vulgaris and pemphigus foliaceus.
Lee MS; Yeh YC; Tu YK; Chan TC
J Am Acad Dermatol; 2021 Jul; 85(1):176-186. PubMed ID: 32798583
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris.
Baskan EB; Yilmaz M; Tunali S; Saricaoglu H
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1432-4. PubMed ID: 19470052
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of rituximab in the treatment of pemphigus vulgaris: A 10-year follow-up.
Laftah Z; Craythorne E; Mufti GJ; du Vivier A
J Oral Pathol Med; 2019 Oct; 48(9):861-862. PubMed ID: 31408552
[No Abstract] [Full Text] [Related]
20. Resolution of a case of pediatric pemphigus vulgaris treated with rituximab.
Didona D; Paolino G; Donati M; Caposeina D; Calvieri S; Didona B
Acta Dermatovenerol Croat; 2014; 22(4):288-90. PubMed ID: 25580789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
